Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive potential in classical galactosemia: A case series based perspective.

European journal of obstetrics & gynecology and reproductive biology: X·2026
Same author

The Potential Role of SGLT2 Inhibitors in Cushing's Disease.

Diabetes, obesity & metabolism·2026
Same author

Disease-specific growth charts capture characteristic growth patterns in children with PMM2 - CDG.

Molecular genetics and metabolism·2026
Same author

Heritability of Long-Term Complications in Classic Galactosemia.

Journal of inherited metabolic disease·2026
Same author

A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsy.

Molecular genetics and metabolism·2026
Same author

Two adult sisters with untreated phenylketonuria: Strikingly discordant clinical phenotype.

Molecular genetics and metabolism reports·2026

Related Experiment Video

Updated: Feb 14, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.1K

Hereditary galactosemia.

Didem Demirbas1, Ana I Coelho2, M Estela Rubio-Gozalbo2

  • 1Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Metabolism: Clinical and Experimental
|February 8, 2018
PubMed
Summary
This summary is machine-generated.

Hereditary galactosemia, a metabolic disorder, stems from defects in Leloir pathway enzymes. Dietary lactose restriction manages acute symptoms but not long-term damage to the brain and gonads.

Keywords:
GalactoseGalactosemiaGeneticsLactoseMetabolism

More Related Videos

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

8.3K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K

Related Experiment Videos

Last Updated: Feb 14, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.1K
Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

8.3K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Hereditary galactosemia is an inborn error of carbohydrate metabolism.
  • It results from autosomal recessive defects in Leloir pathway enzymes: galactokinase (GALK), galactose-1-phosphate uridylyltransferase (GALT), and UDP-galactose 4-epimerase (GALE).
  • Classic galactosemia, caused by severe GALT deficiency, is life-threatening in newborns.

Purpose of the Study:

  • To highlight the limitations of current treatments for galactosemia.
  • To emphasize the need for improved diagnostic tools and understanding of phenotypic variation.
  • To explore novel therapeutic approaches for galactosemia.

Main Methods:

  • Review of existing literature on galactosemia.
  • Analysis of diagnostic tools including molecular genetics and enzyme assays.
  • Discussion of current and potential therapeutic strategies.

Main Results:

  • Dietary lactose restriction effectively resolves acute galactosemia complications.
  • Long-term complications affecting the brain and female gonads persist despite dietary changes.
  • Molecular genetics and GALT enzyme assays are crucial for differentiating galactosemia subtypes.
  • Phenotypic variation within the same genotype necessitates further research for accurate genetic counseling.

Conclusions:

  • Current treatments for galactosemia are insufficient to prevent long-term organ damage.
  • Advanced diagnostic methods are essential for accurate diagnosis and management of galactosemia.
  • Further research into the mechanisms of phenotypic variation and novel therapies is critical.
  • Addressing tissue access and therapeutic windows is key for future treatment efficacy.